Consumer Product Recalls: Eye Wash, Chewable Aspirin Recalls
This article was originally published in The Pink Sheet
Executive Summary
OTC eye washes distributed under Family Care, Major and Rugby brands, and HealthA2Z aspirin are recalled.
You may also be interested in...
Seven Potential Blockbuster Approvals To Look Out For In 2023
After highlighting oncology drugs pegged to make a splash next year with the help of Biomedtracker, Scrip takes a look at seven potential blockbusters across a range of therapeutic areas including neurology, dermatology and blood disorders slated for approval next year.
AviadoBio Targets Rare Form Of Dementia With Gene Therapy
The UK biotech hopes to address a fast-progressing form of dementia that affects people earlier in life with a supplemental gene therapy delivered directly to the brain’s information centre.
UK Avoids 'Cliff Edge' By Extending EU Drug Approval Reliance Procedure
The UK drugs regulator says it needs to make sure that companies do not “deprioritize” GB approval applications while a new “international reliance framework” is being developed.